Jessica Cristini
Medical · Dublin, OHNPI 1528628328
Payments from drug & device makers
Across 151 payments — averaging $20.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Xeris Pharmaceuticals, Inc.$451
- Dexcom, Inc.$439
- Lilly USA, LLC$425
- Novo Nordisk$267
- Bayer$220
- Insulet Corporation$170
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,11399%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 13 | $451 |
| Dexcom, Inc. | 10 | $439 |
| Lilly USA, LLC | 39 | $425 |
| Novo Nordisk | 18 | $267 |
| Bayer | 8 | $220 |
| Insulet Corporation | 6 | $170 |
| Amgen(2 entities) | 6 | $119 |
| Corcept Therapeutics | 5 | $116 |
| Mannkind Corporation | 4 | $114 |
| Boehringer Ingelheim | 4 | $88 |
| Amneal Pharmaceuticals LLC | 4 | $85 |
| Medtronic | 3 | $84 |
| IBSA Pharma Inc. | 4 | $71 |
| Sanofi-aventis U.S. LLC | 3 | $70 |
| Antares Pharma, Inc. | 3 | $54 |
| Tandem Diabetes Care, Inc. | 5 | $52 |
| AbbVie | 2 | $45 |
| Novartis | 2 | $43 |
| Cequr Corporation | 2 | $41 |
| Radius Health, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Pfizer | 1 | $28 |
| Tolmar, Inc. | 1 | $20 |
| Chiesi USA, Inc. | 1 | $15 |
| Lifescan, Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Averitas Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$218
- Wegovy$121
- Kerendia$121
- ZEPBOUND$119
How this compares
$3,133 in reported general payments places this provider in the 85th percentile of 547 medical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 120 | $202,232 |
| MounjaroTirzepatide | 90 | $149,863 |
| TrulicityDulaglutide | 36 | $63,285 |
| JardianceEmpagliflozin | 58 | $58,475 |
| Humalog Kwikpen U-200Insulin Lispro | 19 | $52,431 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 32 | $39,713 |
| Tresiba Flextouch U-100Insulin Degludec | 28 | $35,373 |
| FarxigaDapagliflozin Propanediol | 21 | $27,961 |
| Gvoke Hypopen 2-PackGlucagon | 38 | $22,523 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 15 | $21,975 |
| VascepaIcosapent Ethyl | 22 | $21,047 |
| Repatha SureclickEvolocumab | 17 | $19,505 |
| Novolog FlexpenInsulin Aspart | 20 | $12,872 |
| KerendiaFinerenone | 13 | $11,736 |
| TirosintLevothyroxine Sodium | 32 | $9,507 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $425 | $216,607137 claims |
| Novo NordiskOzempic | $267 | $202,232120 claims |
| Boehringer IngelheimJardiance | $88 | $58,47558 claims |
| AstraZenecaFarxiga | $15 | $27,96121 claims |
| BayerKerendia | $220 | $11,73613 claims |
| IBSA Pharma Inc.Tirosint | $71 | $9,50732 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $85 | $4,474159 claims |
| AbbVieSynthroid | $45 | $4,47159 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 547 medical providers in Ohio.
Other medical in Dublin
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
- Melanie HunglerCincinnati$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.